Definition
The insulin-like growth factors (IGF-I and IGF-II) are structurally related molecules that play essential roles in the regulation of cell survival, growth, proliferation, differentiation, and metabolism. The IGF family is comprised of (i) ligands (IGF-I, IGF-II, and insulin), (ii) six well-characterized high-affinity binding proteins (IGFBP-1−6), (iii) IGFBP proteases, and (iv) cell surface receptors that mediate the biological functions of IGFs. These transmembrane receptors include the IGF-I receptor (IGF-IR), IGF-II/mannose 6-phosphate receptor (IGF-II/M6PR), insulin receptor (IR), and insulin receptor-related receptor (IRR). In many tumor cells, the IGF-IR is often upregulated and/or hyperactivated. Furthermore, increased circulating IGF-I levels are considered a significant risk factor for the development of various types of cancers. Although the oncogenic role of IGFs (i.e., their ability to initiate carcinogenesis) is still under the debate, numerous lines of...
This is a preview of subscription content, log in via an institution.
References
Khandwala HM, McCutcheon IE, Flyvbjerg A et al (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocrine Rev 21:215–244
LeRoith D, Werner H, Beitner-Johnson D et al (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev 16:143–163
Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–518
Rubin R, Baserga R (1995) Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 73:311–331
Samani AA, Yakar S, LeRoith D et al (2007) The role of the IGF system in cancer growth and metastasis; overview and recent insights. Endocrine Rev 28:20–47
See Also
(2012) AKT. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 115. doi: 10.1007/978-3-642-16483-5_163
(2012) Dominant Negative. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1150. doi: 10.1007/978-3-642-16483-5_1705
(2012) MAPK. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2167. doi: 10.1007/978-3-642-16483-5_3532
(2012) Mitogen-Activated Protein Kinase. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2336. doi: 10.1007/978-3-642-16483-5_3770
(2012) Monoclonal Antibody. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2367. doi: 10.1007/978-3-642-16483-5_6842
(2012) P53. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2747. doi: 10.1007/978-3-642-16483-5_4331
(2012) Palliative. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2759. doi: 10.1007/978-3-642-16483-5_4350
(2012) Radiation Therapy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3144. doi: 10.1007/978-3-642-16483-5_4907
(2012) Shc. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3401. doi: 10.1007/978-3-642-16483-5_5284
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Novosiadly, R., LeRoith, D. (2015). Insulin-Like Growth Factors. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_3080-3
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_3080-3
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences